SPONSOR
Boehringer Ingelheim
Total Trials
6
Recruiting
6
Phases
Phase 1, Phase 3, Phase 2
Conditions studied: Patients With Small Cell Lung Carcinoma and Other NeoplasmsInterstitial Lung DiseasesSystemic Autoimmune Rheumatic Diseases Associated Interstitial Lung DiseasesPyoderma GangrenosumDiabetic RetinopathyNon-small Cell Lung CancerHealthy
NCT04429087 Phase 1
Recruiting
A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
Patients With Small Cell Lung Carcinoma and Other Neoplasms
NCT06806592 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Interstitial Lung Diseases
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Pyoderma Gangrenosum
NCT06321302 Phase 2
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Diabetic Retinopathy
NCT07195695 Phase 3
Recruiting
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Non-small Cell Lung Cancer
NCT06745297 Phase 1
Recruiting
A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated
Healthy